ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

In Brief: Middle East Cancer Consortium Formed; Armitage, Mayer Elected To ASCO Positions

May 24, 1996

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012